Yingzhong Li · Q5 response · 'Yeah yeah yeah · Yes' confirming pure empiricism

5/16 Antibody Conference Q&A · Q5 (audience follow-up: ML/simulation usage). Yingzhong's direct affirmation confirms SunVax uses NO ML / NO simulation · pure empirical screening + post-hoc database pattern. This is HANDOFF_TO_m623 signal-1 (AI-moat marketing constraint).

Type

quote

Domain

conference

Grade

conference

License

LIGHT_HOPE_proprietary

Provenance

m622_command_round_12_batch_d_2026-05-17

evidence_grade

B

category

founder_panel_qa

status

draft

instance_tag

sunvax-antibody-2025

quote_text

Confirmation interpretation (per user m624 canonical): - SunVax 不用计算仿真 - SunVax 不用 ML - 纯经验筛选 + 后期数据库 pattern emergence - "We hardly find any useful how to design that. And then we use the very general design methods and then we find some pattern." (per yingzhong-li.md grade B

panel

Antibody_Conference_2026_05_15_Q5

topic

ai_ml_simulation_usage

significance

CRITICAL · founder explicit verbatim disclaimer of ML/simulation moat. This is dual-signal per HANDOFF_TO_m623.md signal-1: (a) Honesty-signal: rare in industry · partnership trust-builder (b) Marketi

speaker_name

Yingzhong Li

speaker_affiliation

SunVax mRNA Therapeutics Inc.

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.